C-peptide level | All-cause mortality | Cardiovascular-related mortality | Coronary artery disease–related mortality | |||
---|---|---|---|---|---|---|
Events, no. (%) | Adjusted HR* (95% CI) | Events, no. (%) | Adjusted HR* (95% CI) | Events, no. (%) | Adjusted HR* (95% CI) | |
Increase per unit of C-peptide | 1.41 (1.27–1.57) | 1.70 (1.41–2.06) | 1.67 (1.27–2.19) | |||
C-peptide quartile, nmol/L | ||||||
Quartile 1 (< 0.440) | 389 (26.4) | 1.00 (ref) | 146 (9.9) | 1.00 (ref) | 88 (6.0) | 1.00 (ref) |
Quartile 2 (0.440–0.692) | 484 (32.7) | 1.33 (1.08–1.63) | 210 (14.2) | 1.62 (1.13–2.33) | 114 (7.7) | 1.52 (0.98–2.36) |
Quartile 3 (0.693–1.018) | 533 (36.1) | 1.56 (1.23–1.98) | 244 (16.5) | 2.45 (1.71–3.51) | 142 (9.6) | 2.11 (1.27–3.50) |
Quartile 4 (> 1.018) | 614 (41.6) | 1.80 (1.33–2.43) | 295 (20.0) | 3.20 (2.07–4.93) | 171 (11.6) | 2.73 (1.55–4.82) |
p value for trend | < 0.001 | < 0.001 | 0.07 |
Note: CI = confidence interval, HR = hazard ratio, ref = reference.
↵* Adjusted for age, sex, ethnic background, education, smoking status, alcohol consumption status, day on which the last meal or snack was consumed, history of hypertension, hypercholesterolemia, heart attack and body mass index, as well as C-reactive protein, total cholesterol, triglyceride, serum insulin, glycated hemoglobin and fasting serum glucose levels.